Search - tctmd.com

Displaying 21 - 40 of 41

Sort: Relevancy | Date

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Presentation TCT 2022

None Use: The Data Are Unconvincing and the Cost Is Prohibitive

Presenter: David J. Cohen

September 17, 2022

Selective Use: Only in Vulnerable Patients

Presentation TCT 2022

Selective Use: Only in Vulnerable Patients

Presenter: John K. Forrest

September 17, 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

News Conference News TCT 2022

New Faces, New Formats, New Tech: What to Expect From TCT 2022

September 07, 2022

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

News Daily News

Higher Annual TAVI Volumes Linked to Greater Use of Embolic Protection

August 23, 2022

TCTMD’s Top 10 Most Popular Stories for June 2022

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for June 2022

July 04, 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

News Conference News SCAI 2022

DISRUPT PAD III: Lithotripsy Prep Linked to Better PAD Patency at 1 Year

May 23, 2022

Wirion Embolic Protection System Recalled Over Filter Breakage

News Daily News

Wirion Embolic Protection System Recalled Over Filter Breakage

January 10, 2022

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

News Conference News TCT 2021

More Complications With Plug Closure After TAVI: CHOICE-CLOSURE

Michael O'Riordan

November 05, 2021

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

News Conference News ESC 2021

ACST-2: Carotid Stenting, Surgery Provide Similar Outcomes in Asymptomatic Patients

August 29, 2021

Lean Antithrombotic Regimen Recommended After TAVI

News Daily News

Lean Antithrombotic Regimen Recommended After TAVI

April 12, 2021

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

News Daily News

Late Cerebrovascular Events ‘Devastating’ in TAVR-Treated Patients

Michael O'Riordan

March 11, 2020

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

News Daily News

Add-on Payment Now in Effect for Sentinel Protection Device During TAVR

October 01, 2018

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

News Daily News

Sentinel Cerebral Embolic Protection Device Acquired by Boston Scientific

July 20, 2018

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

Podcast

Episode 16: Healthcare Reform, Embolic Protection in TAVR, and More

August 10, 2017

Device Design Features and Findings From EU Clinical Trials

Presentation TVT 2017

Device Design Features and Findings From EU Clinical Trials

Presenter: Joachim Schofer

June 15, 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presentation TVT 2017

Device Design Features and Findings From the Meta-Analysis of Three Randomized Clinical Trials

Presenter: Axel Linke

June 15, 2017

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

News Daily News

FDA Clears Sentinel Cerebral Protection Device for Use During TAVR

June 05, 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

News Conference News ACC 2017

ACC 2017: CVD Outcomes for Evolocumab, Intermediate-Risk TAVR, Coronary Physiology Tests, and More

March 10, 2017

News Features

Be It Resolved: How Alcohol Harms or Helps the Heart Remains Controversial—and Confusing

January 04, 2017

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

News Opinion Editor's Corner TCT 2016

My Takeaways From TCT 2016: Surprises, Presuppositions, and the Gift of the Giveaway

November 07, 2016

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.